To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Cost and committee reports

Official records Congress.gov attaches to H.R. 1492.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. MURPHY, as printed in the Congressional Record (Vol. 171, No. 35, February 21, 2025, Page H730):
  Article 1, Section 8
  Source: Congress.gov, Congressional Record February 21, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  20 characters

  Congress.gov bill record

  H.R. 1492, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/1492

  Record last updated by Congress.gov

  September 19, 2026

  PORKER copy retrieved

  September 24, 2026

  Stored copy, SHA-256 of the file

  59f12d632469646b74716db45e23def4fc4d615c55cacd13685fc0a590b7541f

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of September 19, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 1492, last updated September 19, 2026. PORKER’s copy was retrieved September 24, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.